World ADC London
March 20, 2020
March 2-5 2020 | London, UK
World ADC San Diego 2019
October 10, 2019
ReachBio Featured on Sickle Cell Anemia News
August 27, 2019
An article referencing ReachBio's new drug screening platform to discover therapeutic compounds that trigger the production of fetal hemoglobin (HbF) to treat sickle cell disease (SCD) and other....
A Platform for Screening Drugs to Treat Sickle Cell Disease Now Offered by ReachBio
August 13, 2019
SEATTLE, August 13, 2019 -- ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is now offering a drug screening platform to....
ReachBio Research Labs Offers New Services for ADC Off-target Toxicity and Linker Stability
July 22, 2019
SEATTLE, July 9, 2019 -- ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is now offering off-target toxicity and linker....
Applied Pharmaceutical Toxicology 2019
April 25, 2019
Once again, ReachBio is excited to announce our continued sponsorship for the annual Applied Pharmaceutical Toxicology (APT) Conference in South San Francisco, California. This year's event will....
SOT 58th Annual Meeting and ToxExpo
March 08, 2019
ReachBio will be exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 58th Annual Meeting in Baltimore, Maryland. Stop by our booth, #4121, to learn about our latest assays to help....
Applied Pharmaceutical Toxicology 2018
April 10, 2018
ReachBio is excited to announce that we are slated to sponsor this year's Applied Pharmaceutical Toxicology (APT) Conference in Boston, Massachusettsat the Merck Research Laboratories, May 15th....
SOT 57th Annual Meeting and ToxExpo
February 28, 2018
ReachBio will be returning to and exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 57th Annual Meeting in San Antonio, Texas. Our booth, #1631, will display a range of....
ReachBio Research Labs Offers New NK (V158+) Cells Optimized for ADCC Assays online
May 09, 2017
ReachBio's COO, Rob Chaney, talks cellPrism® and growth with CEOCFO Magazine
April 24, 2017
Applied Pharmaceutical Toxicology 2017
April 17, 2017
We're excited to announce we'll be exhibiting at this year's Applied Pharmaceutical Toxicology (APT) Conference in San Francisco, California at Genentech in building 35, May 15th - 17th.
SOT 56th Annual Meeting and ToxExpo
February 15, 2017
We are pleased to announce that ReachBio will be exhibiting at this year’s ToxExpo at the Society of Toxicology (SOT) 56th Annual Meeting in Baltimore, Maryland. Our booth, number 1616, will....
ReachBio Research Labs Launches a New Drug Development Platform, cellPrism®
January 31, 2017
SEATTLE, Jan. 31, 2017 /PRNewswire/ -- ReachBio Research Labs (trade name under Reachbio LLC®) has announced the launch of their new drug development platform, cellPrism®. The platform is designed to....
Human PBMCs Available Online
June 20, 2016
World Preclinical Congress 2016
June 01, 2016
Happy New Year from ReachBio Research Labs!
December 31, 2015
It has been a good year for growth at ReachBio Research Labs! We have really appreciated working with our existing clients who have come back, time after time with new contract services. We have....
Thank you for visiting us at ACT 2015!
November 12, 2015
Thank you to everyone who took the time to visit with us at the American College of Toxicology (ACT) 2015 36th Annual Meeting, this week. We had a great time, and look forward to seeing everyone,....
Effects of Compounds on Thrombopoiesis: Beyond the CFU-Mk Colony Assay
September 11, 2014
The colony forming unit-megakaryocyte assay, better known as the CFU-Mk assay is a robust and predictive in vitro assay for evaluating the toxicity of test compounds on megakaryocytic progenitors.....
Hemotoxicity Testing: Predictive Lineage-Specific In Vitro Assay Services by ReachBio Research Labs
May 12, 2014
If your drug development program has a particular lineage-specific hemotoxicity issue such as neutropenia (myeloid lineage toxicity), acute anemia (erythroid lineage toxicity) or thrombocytopenia....
ReachBio's Posters Presented at SOT 2014 Are Now Available to Download
April 10, 2014
Interested in in vitro assays to assess the risk of cytokine storms? Or in vitro evaluation of compound effects on leukemic progenitors vs normal progenitors? So are we!
February 27, 2014
SOT 2014 Posters Available for Download!
ReachBio Research Labs presented the following posters at the recent Society of Toxicology conference in Phoenix, AZ. Click on the title to download a copy.
Hemotoxicity Testing Services - Are you Eligible for Multi-Assay Discounts?
February 15, 2014
Our in vitro hemotoxicity testing services can provide valuable predictive information regarding compound-induced hemotoxicity on specific lineages: myeloid (CFU-GM assays), erythroid (BFU-E assays)....